Argomed's Unattributed VC - II Round

Argomed raised a round of funding on May 19, 1999. Investors include Global Life Science Ventures.

Company developing a proprietary, water-induced thermotherapy device and technique to address the non-surgical treatment of benign prostatic hyperplasia (BPH). BPH is a condition that afflicts the maj…

Articles about Argomed's Unattributed VC - II Round: